153 related articles for article (PubMed ID: 24013228)
1. BMP4/Thrombospondin-1 loop paracrinically inhibits tumor angiogenesis and suppresses the growth of solid tumors.
Tsuchida R; Osawa T; Wang F; Nishii R; Das B; Tsuchida S; Muramatsu M; Takahashi T; Inoue T; Wada Y; Minami T; Yuasa Y; Shibuya M
Oncogene; 2014 Jul; 33(29):3803-11. PubMed ID: 24013228
[TBL] [Abstract][Full Text] [Related]
2. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
[TBL] [Abstract][Full Text] [Related]
3. Thrombospondin-1 suppresses tumorigenesis and angiogenesis in serum- and anchorage-independent NIH 3T3 cells.
Castle VP; Dixit VM; Polverini PJ
Lab Invest; 1997 Jul; 77(1):51-61. PubMed ID: 9251678
[TBL] [Abstract][Full Text] [Related]
4. Fstl1 Promotes Glioma Growth Through the BMP4/Smad1/5/8 Signaling Pathway.
Jin X; Nie E; Zhou X; Zeng A; Yu T; Zhi T; Jiang K; Wang Y; Zhang J; You Y
Cell Physiol Biochem; 2017; 44(4):1616-1628. PubMed ID: 29212066
[TBL] [Abstract][Full Text] [Related]
5. Aerosol delivery of PEI-p53 complexes inhibits B16-F10 lung metastases through regulation of angiogenesis.
Gautam A; Densmore CL; Melton S; Golunski E; Waldrep JC
Cancer Gene Ther; 2002 Jan; 9(1):28-36. PubMed ID: 11916242
[TBL] [Abstract][Full Text] [Related]
6. Transient potential receptor channel 4 controls thrombospondin-1 secretion and angiogenesis in renal cell carcinoma.
Veliceasa D; Ivanovic M; Hoepfner FT; Thumbikat P; Volpert OV; Smith ND
FEBS J; 2007 Dec; 274(24):6365-77. PubMed ID: 18021253
[TBL] [Abstract][Full Text] [Related]
7. Androgens repress the expression of the angiogenesis inhibitor thrombospondin-1 in normal and neoplastic prostate.
Colombel M; Filleur S; Fournier P; Merle C; Guglielmi J; Courtin A; Degeorges A; Serre CM; Bouvier R; Clézardin P; Cabon F
Cancer Res; 2005 Jan; 65(1):300-8. PubMed ID: 15665307
[TBL] [Abstract][Full Text] [Related]
8. Functional characterization of bone morphogenetic protein binding sites and Smad1/5 activation in human vascular cells.
Upton PD; Long L; Trembath RC; Morrell NW
Mol Pharmacol; 2008 Feb; 73(2):539-52. PubMed ID: 17989347
[TBL] [Abstract][Full Text] [Related]
9. ADAM12 Is a Novel Regulator of Tumor Angiogenesis via STAT3 Signaling.
Roy R; Dagher A; Butterfield C; Moses MA
Mol Cancer Res; 2017 Nov; 15(11):1608-1622. PubMed ID: 28765266
[TBL] [Abstract][Full Text] [Related]
10. BMP4 promotes human Sertoli cell proliferation via Smad1/5 and ID2/3 pathway and its abnormality is associated with azoospermia.
Hai Y; Sun M; Niu M; Yuan Q; Guo Y; Li Z; He Z
Discov Med; 2015 Apr; 19(105):311-25. PubMed ID: 25977194
[TBL] [Abstract][Full Text] [Related]
11. SKLB1002, a novel potent inhibitor of VEGF receptor 2 signaling, inhibits angiogenesis and tumor growth in vivo.
Zhang S; Cao Z; Tian H; Shen G; Ma Y; Xie H; Liu Y; Zhao C; Deng S; Yang Y; Zheng R; Li W; Zhang N; Liu S; Wang W; Dai L; Shi S; Cheng L; Pan Y; Feng S; Zhao X; Deng H; Yang S; Wei Y
Clin Cancer Res; 2011 Jul; 17(13):4439-50. PubMed ID: 21622720
[TBL] [Abstract][Full Text] [Related]
12. In vivo mechanisms by which tumors producing thrombospondin 1 bypass its inhibitory effects.
Filleur S; Volpert OV; Degeorges A; Voland C; Reiher F; Clézardin P; Bouck N; Cabon F
Genes Dev; 2001 Jun; 15(11):1373-82. PubMed ID: 11390357
[TBL] [Abstract][Full Text] [Related]
13. Thrombospondin-1 expression in melanoma is blocked by methylation and targeted reversal by 5-Aza-deoxycytidine suppresses angiogenesis.
Lindner DJ; Wu Y; Haney R; Jacobs BS; Fruehauf JP; Tuthill R; Borden EC
Matrix Biol; 2013 Mar; 32(2):123-32. PubMed ID: 23202046
[TBL] [Abstract][Full Text] [Related]
14. Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor.
Sun J; Blaskovich MA; Jain RK; Delarue F; Paris D; Brem S; Wotoczek-Obadia M; Lin Q; Coppola D; Choi K; Mullan M; Hamilton AD; Sebti SM
Cancer Res; 2004 May; 64(10):3586-92. PubMed ID: 15150116
[TBL] [Abstract][Full Text] [Related]
15. Regulation of tumor growth and metastasis by thrombospondin-1.
Roberts DD
FASEB J; 1996 Aug; 10(10):1183-91. PubMed ID: 8751720
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of Rab37-Mediated Cross-talk between Cancer Cells and Endothelial Cells via Thrombospondin-1 Promotes Tumor Neovasculature and Metastasis.
Tzeng HT; Tsai CH; Yen YT; Cheng HC; Chen YC; Pu SW; Wang YS; Shan YS; Tseng YL; Su WC; Lai WW; Wu LW; Wang YC
Clin Cancer Res; 2017 May; 23(9):2335-2345. PubMed ID: 28151721
[No Abstract] [Full Text] [Related]
17. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
18. SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth.
Filleur S; Courtin A; Ait-Si-Ali S; Guglielmi J; Merle C; Harel-Bellan A; Clézardin P; Cabon F
Cancer Res; 2003 Jul; 63(14):3919-22. PubMed ID: 12873985
[TBL] [Abstract][Full Text] [Related]
19. Responses of vascular endothelial cells to angiogenic signaling are important for tumor cell survival.
Shan S; Robson ND; Cao Y; Qiao T; Li CY; Kontos CD; Garcia-Blanco M; Dewhirst MW
FASEB J; 2004 Feb; 18(2):326-8. PubMed ID: 14688196
[TBL] [Abstract][Full Text] [Related]
20. Retinoic acid inhibits angiogenesis and tumor growth of thyroid cancer cells.
Hoffmann S; Rockenstein A; Ramaswamy A; Celik I; Wunderlich A; Lingelbach S; Hofbauer LC; Zielke A
Mol Cell Endocrinol; 2007 Jan; 264(1-2):74-81. PubMed ID: 17101211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]